The results showed that CD8+ cytotoxic T lymphocytes increased significantly in the SNCSS(Cas9/sgGDF15) treatment group compared to the control group in both HCC models (Figure S11E,F, Supporting Information). Here, CD8A is linked to hepatocellular carcinoma.